display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced RCC (mRCC) - (neo)adjuvant(NA)metastatic/advanced RCC (mRCC) - 1st line (L1)metastatic/advanced RCC (mRCC) - 2nd line (L2)
metastatic/advanced RCC (mRCC) - (neo)adjuvant(NA)metastatic/advanced RCC (mRCC) - 1st line (L1)metastatic/advanced RCC (mRCC) - 2nd line (L2)
nivolumab based treatment
nivolumab alone CheckMate 914 CheckMate 025
nivolumab plus cabozantinib CheckMate 9ER

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons